What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
Answer from: Radiation Oncologist at Community Practice
The FAST-Forward boost trial will be informative here, and I would recommend reading the protocol, because one can consider using the standard arm now, which is 40 Gy to the breast (and nodes, when RNI is indicated), and a 48 Gy boost, all in 15 fractions. This dose is recognizable as the breast boo...
Comments
Radiation Oncologist at Cancer Care Centers of Brevard No use of chemosensitization with something like X...
Radiation Oncologist at Stroger Hospital Interesting facts regarding a/b.
Radiation Oncologist at Firelands Regional Medical Center Excellent response and rationale. Thank you.
Radiation Oncologist at Baylor College of Medicine Department of Radiation Oncology Re: xeloda, on the trial they don't allow concurre...
Answer from: Radiation Oncologist at Academic Institution
Good question. For both supraclavicular and axillary gross nodes, the issues are quite similar; i.e., the brachial plexus makes it challenging to give a high enough dose to control gross disease. A few thoughts:
For gross disease, it is always good to consider adding concurrent chemo as a sensiti...
Comments
Radiation Oncologist at Swedish Covenant Hospital (Chicago IL) In those whom you have treated to <65 Gy, have ...
Radiation Oncologist at Wellspan Sechler Family Cancer Center Way back when the earth was young, I had a young m...
No use of chemosensitization with something like X...
Interesting facts regarding a/b.
Excellent response and rationale. Thank you.
Re: xeloda, on the trial they don't allow concurre...